Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11 USD | +0.36% | -8.33% | +79.74% |
May. 14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
May. 13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | 418K | Sales 2025 * | 19.8M | Capitalization | 285M |
---|---|---|---|---|---|
Net income 2024 * | -120M | Net income 2025 * | -100M | EV / Sales 2024 * | 682 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 14.4 x |
P/E ratio 2024 * |
-2.55
x | P/E ratio 2025 * |
-3.64
x | Employees | 122 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.4% |
Latest transcript on Inovio Pharmaceuticals, Inc.
1 day | +0.36% | ||
1 week | -8.33% | ||
Current month | -3.93% | ||
1 month | +8.27% | ||
3 months | +39.68% | ||
6 months | +118.77% | ||
Current year | +79.74% |
Managers | Title | Age | Since |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 19-03-24 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 02-05-31 |
Chief Tech/Sci/R&D Officer | - | 07-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 03-11-30 |
Lota Zoth
BRD | Director/Board Member | 64 | 17-12-31 |
Jay Shepard
BRD | Director/Board Member | 65 | 20-01-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 1,487 M€ | +8.80% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 11 | +0.36% | 222,504 |
24-05-23 | 10.96 | -2.58% | 316,160 |
24-05-22 | 11.25 | +2.37% | 527,950 |
24-05-21 | 10.99 | -1.08% | 236,020 |
24-05-20 | 11.11 | -7.42% | 340,905 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+79.74% | 285M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- INO Stock